Combining a phage cocktail with antibiotics improves recovery from Pseudomonas-induced VAP in mice
Geraldine Nouailles(Humboldt-Universität zu Berlin), J Li(Humboldt-Universität zu Berlin), Matthias Felten(Humboldt-Universität zu Berlin), Jean-Damien Ricard(Inserm), Ulrike Behrendt(Humboldt-Universität zu Berlin), Magdalena Bürkle(Humboldt-Universität zu Berlin), Antonia Dannheim(Fraunhofer Institute for Toxicology and Experimental Medicine), Martin Witzenrath(Humboldt-Universität zu Berlin), Baptiste Gaborieau(Centre National de la Recherche Scientifique), Laurent Debarbieux(Institut Pasteur), Christine H. Rohde(Leibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures), Imke H. E. Korf(Fraunhofer Institute for Toxicology and Experimental Medicine), Holger Ziehr(Fraunhofer Institute for Toxicology and Experimental Medicine), S Wienecke(Fraunhofer Institute for Toxicology and Experimental Medicine)
Cited by 0
Related Papers
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model
|Cell|2020|387
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
|Science|2020|382
The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?
|Pharmaceutical Research|2010|298